Nuwellis

Aquapheresis therapy, delivered by the Aquadex FlexFlow system, uses a simplified approach to ultrafiltration for the removal of salt and water in patients with Hypervolemia, or fluid overload. Compared to renal replacement devices used for ultrafiltration, the Aquadex FlexFlow system is smaller and more portable. By removing excess salt and water in a safe, predictable, and effective manner, the Aquadex FlexFlow is intended to improve symptoms and clinical outcomes and enables the focus to be on treating the underlying clinical condition, whatever it may be. Physicians can specify and adjust the exact amount and rate of fluid to be removed from each patient, resulting in a gradual reduction that has been shown to have no significant clinical impact on blood pressure, heart rate, or the balance of electrolytes (e.g. sodium, potassium, etc.) in the body.